Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutininLarry Smith, Ronald B. Moss, Souphaphone Boutsaboualoy et al.|Vaccine|2010Cited by 142
Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous DoseScott A. Halperin, David Allison, Catherine Donovan et al.|Journal of the Pediatric Infectious Diseases Society|2018Cited by 27